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Scientists are going to discover many subtle genetic factors in the makeup of human
beings. . . . Once we can say that there are differences between people that are easily
demonstrable at the genetic level, then society will have to come to grips with
understanding diversity—and we are not prepared for that.
David Baltimore, American microbiologist, 1983
Gene Therapy 
for CF
New research on gene replacement therapy
offers the hope of a cure for cystic fibrosis
(CF). This fatal disease, symptomized by
coughing, wheezing, lung infections, very
salty sweat, and excessive appetite with
inability to gain weight, affects about
30,000 Americans. 
CF manifests when a person receives a
mutated copy of the CFTR gene from both
parents. More than 10 million people carry
one copy of the defective  gene. Most CF
patients die in childhood, but some live
into their 30s or 40s. Advances in drug
therapies and other treatments such as lung
transplants have improved the quality of
life of CF patients in recent years, but still
do not offer a cure. 
Because lung infections are responsible
for most CF fatalities, research into gene
therapy for treating the disease has initially
focused on replacing the mutant genes in
the epithelial cells lining the lungs and nasal
passages. But the human body has evolved a
complex system to prevent invasion of for-
eign DNA, and the lungs have a particularly
strong defense system. So scientists need to
find a way to “trick” the cells into accepting
replacement genes. In a report in the June
2000 issue of Nature Biotechnology, Silvia
M. Kreda, a clinical research associate of
medicine at the
University of North
Carolina at Chapel
Hill, and colleagues
describe research
with a particular
type of airway re-
ceptor molecule
that may offer a
reliable pathway
into cells. 
Instead of pro-
ducing the normal
protein that forms
channels in cell
membranes for the
passage of salt out
of cells, people
with CF produce a
faulty protein,
which causes a
thick mucus that
impairs function
of the lungs, intes-
tines, and other
organs. If healthy
genes can be trans-
ferred into the CF
patient’s cells, the-
oretically they
should produce
the protein prod-
uct necessary to
form the channels
for proper elec-
trolyte transport
out of the airway
cells. 
Kreda and colleagues identified the
P2Y2 molecule receptor on the membrane
surface of the lungs as a potential target for
shuttling healthy genes into the airway pas-
sages. Their research strategy was to com-
bine the nucleotide UTP, which binds to
certain receptor molecules on the outside
of the epithelial cells, with a commonly
used vector known as an adenovirus. Using
reporter genes to signal a successful trans-
genic event, Kreda’s group demonstrated
that UTP linked to the vector and facilitat-
ed its uptake into the cell. Additional
experiments revealed that when UTP was
linked to an adenovirus vector, in vitro
transfer of the reporter gene into human
lung cells was successful. 
Kreda emphasizes that her lab is work-
ing on a model system for improving entry
mechanisms in gene replacement. Before
clinical trials with humans can be consid-
ered, however, vector construction needs
to be refined for improved efficiency.
Richard C. Boucher, the principal investi-
gator for the study, says that although
UTP is effective at binding to receptor
sites on the membrane, it is rapidly degrad-
ed by the body’s enzymes and is therefore
not efficient for delivering the gene pay-
load. Future in vitro experiments using the
CFTR gene will measure channel activity
to determine gene therapy’s ability to cor-
rect the mutant gene. When the in vitro
system is perfected, efficacy will be tested
in animal models. A reporter gene will be
transferred via the adenovirus vector into
normal mice to verify gene expression.
Then the CFTR gene will be introduced
into knockout mice to determine whether
the corrected gene is accepted into live cells
in the respiratory tract. 
The adenovirus, a DNA-containing
virus that causes upper respiratory tract
infections, is widely used as a vector in CF
research because it is an established model
that works well. It can pose a danger of
infection to patients, however, and research
is ongoing to address the safety issues of
using adenovirus vectors in human studies,
and to find safer vectors for gene replace-
ment therapy. In September 2000, a panel
of the American Association for the
Advancement of Science called for a mora-
torium on gene-altering research and for the
government to establish an oversight board
as soon as possible. –Mary Eubanks
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UTP-based conjugates for gene replacement therapy. Scientists have
found that the P2Y2 receptor is a viable target for gene therapy vectors
seeking to transport a payload of healthy genes into airway passage tissues
of CF patients.T
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Pulling the Plug on
POPs 
Officials from the United Nations
announced on 10 December 2000 that rep-
resentatives from 122 countries have agreed
on the text of a treaty banning or sharply
restricting the use of 12 highly toxic chemi-
cals known as persistent organic pollutants
(POPs). The treaty will be formally adopted
during a diplomatic conference in
Stockholm, Sweden, to be held 22–23 May
2001. After this, governments will ratify the
treaty. The treaty will go into force once 50
nations have ratified it, a process estimated
to take 3–5 years. 
POPs travel easily through the environ-
ment and break down slowly. They have
been linked with cancer, allergies, central and
peripheral nervous system damage, immune
disorders, birth defects, and other adverse
effects, and can be transferred from mother
to child through breast-feeding. In a 10
December 2000 press release by the United
Nations Environment Programme, which
organized the talks, session chairman John
Buccini said, “Persistent organic pollutants
threaten the health and well-being of humans
and wildlife in every region of the world.
This new treaty will protect present and
future generations from the cancers, birth
defects, and other tragedies caused by POPs.”
The six-day session was held in
Johannesburg, South Africa. It was the fifth
time that diplomats met to work on guide-
lines for addressing POPs pollution at an
international level. The treaty establishes
control measures for the production,
import, export, disposal, and use of an ini-
tial list of 12 highly toxic POPs, the so-
called “dirty dozen.” Eight of the chemicals
may no longer be produced or used once
the treaty goes into effect. 
Exceptions have been granted for DDT,
polychlorinated biphenyls (PCBs), dioxins,
and furans. Until safer solutions can be
developed, DDT may still be used in cer-
tain nations to combat malaria-carrying
mosquitoes. PCBs will still be around in
the form of electrical equipment such as
transformers, which benefit from the chem-
icals’ excellent dielectric properties.
Governments will have until 2025 to
arrange for PCB-free replacements. Finally,
because dioxins and furans are unintention-
al by-products of burning and industrial
processes, they are harder to control.
Governments are therefore being asked to
reduce their releases with an eye toward
eventually eliminating them altogether.
The treaty is intended to be a flexible
policy tool that can be expanded and updat-
ed in the future as needed. A POPs Review
Committee will regularly consider other
POPs candidates for control to ensure that
the treaty reflects the state of the science.
–Susan M. Booker
Virus Targets Amphibians
On 8 August 2000, USGS scientists announced
their finding that an emerging iridovirus
disease is partially to blame for a large die-off
of western tiger salamanders in North
Dakota. The same disease has also been
linked to declines in the
populations of multiple
amphibian species in the
Midwest and in eastern
sections of the United
States. 
USGS researcher
David Mushet says the recent die-off is the first
amphibian mortality event due to disease
recorded at the U.S. Fish and Wildlife Service’s
Cottonwood Lake Study Area of North Dakota
since data gathering began in 1967. The
scientists are working to establish whether the
localized die-offs are part of a long-term
worldwide amphibian decline that is only now
being uncovered due to a greater emphasis
being placed on amphibian population
surveillance in recent years. 
Protecting Parks from
Pollution
Continued declining air quality in U.S.
national parks prompted officials at the
Department of the Interior to draft a letter to
the EPA on 19 July 2000 requesting that the
agency adopt a general regulation to protect
resources within parks from the effects of air
pollution. These effects range from decreased
visibility to plant damage caused by nitrous
oxide and other pollutants.
The National Parks Conservation
Association, a watchdog organization, has
found that visibility in the Great Smoky
Mountains National Park has been reduced
from its historic 93 miles to as low as 15 miles
during recent summers. The group also says
that much of the ozone pollution within the
parks is coming from motor vehicles, and that
the EPA is not regulating such pollution
strongly enough. 
Fool’s Gold Mining
Millions of dollars’ worth of gold has been
illegally extracted from a gold mine in the
Manado area of Indonesia, according to a 31
July 2000 BBC news report.
Trespassing miners use
large quantities of mercury
to separate gold from
surrounding materials.
Toxic by-products of this
process are dumped directly
on the soil. An estimated 200 metric tons of
mercury was released in the area during the
first half of 2000. Environmental scientists
have determined that mercury has made its
way into nearby waters, which the local
population of 400,000 depends on for food
and fishing income.
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Aldrin (pesticide)
Chlordane (pesticide)
DDT (pesticide)
Dieldrin (pesticide)
Dioxins (burning/industrial by-products)
Endrin (pesticide)
Furans (burning/industrial by-products)
Heptachlor (pesticide)
Hexachlorobenzene (pesticide and industrial chemical)
Mirex (pesticide)
Polychlorinated biphenyls (industrial chemicals)
Toxaphene (pesticide)
POPs to GoG
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Awards Remember
Rall
Two new awards pay tribute to David P.
Rall, the former NIEHS and National
Toxicology Program director, who died in
September 1999. Rall was a pioneer in the
field of environmental health science, and is
widely hailed for his work as an advocate for
incorporating science-based prevention into
public health policy.
In November, Eula Bingham, a profes-
sor of environmental health at the
University of Cincinnati College of
Medicine, received the David P. Rall Award
for Advocacy in Public Health from the
American Public Health Association.
Bingham worked as assistant secretary of the
Occupational Safety and Health Admin-
istration from 1977 to 1981. The award
recognizes Bingham for her outstanding
record of accomplishments in fighting to
protect workers, consumers, and citizens
from the danger of environmental and
industrial disease. She was instrumental in
the passage of the first community right-to-
know program, in Cincinnati, which
allowed workers access to their company
medical records and records of toxicants in
the workplace, and also called for chemical
labels and worker education programs to
help employees understand the labels.
“[Bingham’s] scientific and ethical stan-
dards have always been of the highest order,
and her dedication to and outspokenness on
occupational health issues during her long
career . . . have always been an inspiration
to me and to many of her students and col-
leagues,” says John Bucher, deputy director
of the NIEHS Environmental Toxicology
Program.
Stuart Bondurant, a professor of medi-
cine and dean emeritus of the University of
North Carolina at Chapel Hill School of
Medicine, was honored in October with the
David Rall Medal, given by the Institute of
Medicine for particularly distinguished lead-
ership as a chair of a study committee or
similar activity. Bondurant is past president
of the Association of American Medical
Colleges and the former acting president of
the Institute of Medicine.
In his years with the Institute of
Medicine, Bondurant exhibited outstanding
leadership as the chair of committees on
controversial and highly visible topics, the
selection committee said, citing his objec-
tive, balanced, and skilled work on groups
studying the safety of silicone breast
implants and the science base for tobacco
harm reduction.
Bondurant says he has “unqualified
respect” for Rall, and adds, “Many of the
things we do today are legacies of his wis-
dom.” –Lindsey A. Greene
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Too Clean for Comfort
A research survey of liquid and solid soaps from
across the country reveals that 45% contained
antibacterial agents—chemicals that scientists say
may not benefit human health but might instead
create stronger bugs. In a presentation at the annu-
al meeting of the Infectious Diseases Society of
America in September 2000, Eli N. Perencevich, a
research fellow in infectious diseases at Beth Israel
Deaconess Medical Center in Boston, and col-
leagues described how they went through the lists
of liquid and solid soaps sold in 23 national and
local stores to see how many of them contained
antibacterial agents. 
Perencevich and colleagues examined 395
national brand liquid soaps and 733 bar soaps on
display at stores in 10 states across the country. They found that 76%
of the liquid soaps contained triclosan and about 30% of the bar
soaps contained triclocarban. “Recent research into the action of tri-
closan has raised the concern that these products may encourage resis-
tance to triclosan and other microbial agents,” Perencevich says.
“With so many of these products on the market, consumers may not
realize they are purchasing soaps that contain antimicrobials. Perhaps
people should check the products’ ingredients closely when they
make their next soap purchase.”
“Although triclosan has been used as an antimicrobial for many
years, it’s only recently that we have learned how it acts on bacte-
ria,” says Stuart Levy, a professor of molecular biology at the Tufts
University School of Medicine in Boston and president of the
Boston-based Alliance for the Prudent Use of Antibiotics. “There is
a specific gene in Escherichia coli and many other bacteria that pro-
duces an enzyme to make the cell wall. Triclosan disrupts the
enzyme so that the bacteria can’t make the cell wall, and therefore,
cannot replicate.” According to Levy, if there is a mutation in this
gene, it may lead to bacteria that are resistant to triclosan or other
antibiotic agents. “Triclosan doesn’t cause a mutation,” he says,
“but by killing normal bacteria it creates an environment where the
resistant, mutated
bacteria are more
likely to survive.”
“No one has ever
been able to prove
that using antibacteri-
al soaps meant that
anyone was better off
than those using stan-
dard soap,” says
Perencevich. “There
has been no scientific
data published to
support the claim
that adding these compounds to household products prevents in-
fection. However, there are studies that suggest use of such products
kills off the sensitive bacteria, leaving hardier bacteria such as E. coli
and Staphylococcus aureus, which could be detrimental to health.”
Perencevich adds, “The fear is that use of these products will result in
bacteria that live longer.”
That fear may be misplaced, contend industry representatives.
“The rising incidence of antibiotic drug–resistant bacteria is a seri-
ous worldwide concern,” says Jerry McEwen, vice president for sci-
ence at the Cosmetic, Toiletry, and Fragrance Association, based in
Washington, D.C. “There is no real-life evidence that antibacterial
products—as they are normally used in hospitals, in food prepara-
tion, and in people’s homes—contribute to bacterial resistance.” He
continues, “While some studies have shown that antibacterial ingre-
dients may promote resistant bacteria, these studies have been done
under controlled laboratory conditions that do not reflect what hap-
pens to bacteria that consumers encounter in the real world.”
Nevertheless, says Perencevich, “The magnitude of the availabil-
ity of antibacterial soap products that we documented in our survey
is cause for concern. This study suggests that further surveillance
and study of triclosan resistance is warranted.” –Ed Susman
HONORS AND AWARDS
INFECTIOUS DISEASET
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The Human Genome Project (HGP) began in 1990 as a collaboration of
the U.S. Department of Energy (DOE) and the National Institutes of
Health (NIH). The project’s goals include designing detailed genetic and
physical maps of the human genome to determine the complete
nucleotide sequence of the three billion base pairs that comprise human
DNA and to identify the estimated 100,000 genes within the human
genome. While developing tools for data analysis, the project also aspires
to store this information in a database. 
To provide both background and updates on this ambitious under-
taking, the DOE and the NIH have established the HGP Information Web
site, located at http://www.ornl.gov/hgmis/. The site hosts HGP resources
ranging from answers to basic questions like “what is a genome” to
information on the project’s latest discoveries. 
Under the Project Information heading, visitors can click on What’s
New to read the continuously updated Genetics
in the News or the Research Digest, which
announces consortia and recent research
developments. The Media Guide link leads
to basic and background information,
including Genetics 101, a fact sheet
explaining the DOE’s involvement in the
HGP, a link to the National Human
Genome Research Institute home page,
information on goals and grants, and a glos-
sary of genetic terms. This link also leads to a
genome image gallery. 
More technical information is available through links under the
Research heading, including resources on sequencing, mapping, instru-
mentation, and informatics with HGP updates. The Research in Progress
link leads to Web sites that display the entire working draft sequence of
the human genome and provide tools for its use. The U.S. & International
Research Sites link leads to other research organizations that have con-
tributed to genetic research. The Chromosome Launchpad link directs vis-
itors to gene maps, sequences, and associated genetic disorders for indi-
vidual chromosomes. And the BACs [Bacterial Artificial Chromosomes]
link accesses a database that is the preferred clone resource for generat-
ing draft sequences of the human genome.
The Educational Resources section provides background publications,
videos, posters, teaching aids, and bioscience career resources for stu-
dents and teachers. For information on gene testing, genetic counseling,
and the various tests available, users can click on the Medicine section.
Here, health care providers can also explore links related to continuing
medical education in genomics and other professional resources.
Various articles on genetic privacy, discrimination against gene thera-
py, and genetics in the courtroom are referenced under the Ethical,
Legal, and Social Issues heading, which mentions that 3–5% of the HGP’s
annual budget goes toward studying the ethical, legal, and social impli-
cations surrounding the availability of genetic information. This repre-
sents the world’s largest bioethics program, a model for programs
around the world. –Lindsey A. Greene
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The Amazing Dissolving
Computer
Cornell University materials scientists have
developed a new epoxy called Alpha-Terp
that could lead to 100% recycling of
computers. Currently, only about one-
quarter of the circuit boards
from the more than 20
million computers
disposed of annually are
broken down into
recyclable parts because
they are sealed with super-
strong epoxy adhesives that
prevent them from being totally
disassembled. 
When heated to 374°F, the new epoxy’s
chemical bonds begin to break down. It
can then be dissolved with a common
industrial solvent to allow repair or
dismantling of the circuit board. The new
epoxy was reported at the August 2000
meeting of the American Chemical Society.
Shocking Food Treatment
Electrolyzed water, produced by applying
an electric current to a dilute saltwater
solution, may serve a variety of food
treatment purposes, according to
University of Georgia scientist Yen-Con
Hung. Devices to produce electrolyzed
water are manufactured in Japan but have
not yet made their way onto the
U.S. market. 
Electrolyzed water is
highly acidic. Chlorine is
produced when the
electric current passes
through the saltwater
solution. According to
Hung, the chlorine and
other unidentified oxidant
by-products kill bacteria more
effectively in some cases than either heat
or chlorinated water alone. In tests, the
electrolyzed water killed bacteria without
changing foods’ color or smell. Hung
found that soaking cutting boards in warm
electrolyzed water for just five minutes
reduced bacteria by up to one millionfold. 
Hung plans to test electrolyzed water
on chicken to see if it kills Salmonella and
Campylobacter on poultry carcasses. He
also plans to test the water on hard-to-
treat products such as oysters. 